$4.55
0.66% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US64157F1030
Symbol
NVRO
Sector

Nevro Stock price

$4.55
-0.03 0.66% 1M
-4.84 51.54% 6M
-16.97 78.86% YTD
-11.96 72.44% 1Y
-88.04 95.09% 3Y
-107.70 95.95% 5Y
-22.96 83.46% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.03 0.66%
ISIN
US64157F1030
Symbol
NVRO
Sector

Key metrics

Market capitalization $170.50m
Enterprise Value $140.39m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.33
P/S ratio (TTM) P/S ratio 0.41
P/B ratio (TTM) P/B ratio 0.62
Revenue growth (TTM) Revenue growth -0.87%
Revenue (TTM) Revenue $419.15m
EBIT (operating result TTM) EBIT $-83.48m
Free Cash Flow (TTM) Free Cash Flow $-62.77m
Cash position $277.04m
EPS (TTM) EPS $-1.89
P/E forward negative
P/S forward 0.42
EV/Sales forward 0.35
Short interest 9.70%
Show more

Is Nevro a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Nevro Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Nevro forecast:

11x Hold
73%
4x Sell
27%

Analyst Opinions

15 Analysts have issued a Nevro forecast:

Hold
73%
Sell
27%

Financial data from Nevro

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
419 419
1% 1%
100%
- Direct Costs 148 148
1% 1%
35%
271 271
1% 1%
65%
- Selling and Administrative Expenses 289 289
8% 8%
69%
- Research and Development Expense 52 52
7% 7%
12%
-70 -70
27% 27%
-17%
- Depreciation and Amortization 14 14
27% 27%
3%
EBIT (Operating Income) EBIT -83 -83
22% 22%
-20%
Net Profit -69 -69
32% 32%
-17%

In millions USD.

Don't miss a Thing! We will send you all news about Nevro directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nevro Stock News

Neutral
PRNewsWire
8 days ago
Furthering Nevro's body of evidence as an innovation leader in pain management, da ta highlights the company's posterior integrated transfixation cage system REDWOOD CITY, Calif. , Nov. 18, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced the publication of ...
Neutral
PRNewsWire
11 days ago
REDWOOD CITY, Calif. , Nov. 15, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on November 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 37,726 shares of Nevro's common stock...
Neutral
PRNewsWire
14 days ago
HFX iQ is the first and only spinal cord stimulation (SCS) system integrating high-frequency SCS landmark evidence with cloud data insights, leading the way for personalized, data-driven patient care* REDWOOD CITY, Calif. , Nov. 12, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chroni...
More Nevro News

Company Profile

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.

Head office United States
CEO Kevin Thornal
Employees 1,215
Founded 2006
Website www.nevro.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today